Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy

Immunotherapy has achieved great success recently and opened a new avenue for anti-tumor treatment. Programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) are typical immune checkpoints that transmit coinhibitory signals, muting the host immunity. Monoclonal antibodies that block PD-1/P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Shuangneng, Chen, Zhaojun, Chen, Dugang, Yan, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086210/
https://www.ncbi.nlm.nih.gov/pubmed/37056572
http://dx.doi.org/10.7150/thno.80091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086210/
https://www.ncbi.nlm.nih.gov/pubmed/37056572
http://dx.doi.org/10.7150/thno.80091

Ejemplares similares